Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir

mAbs

Volumn 8, Issue 6, 2016, Pages 1156-1166

  Ren, Huanhuan ^a   Wang, Guiqin ^a   Wang, Shuangshuang ^a   Chen, Honglin ^b   Chen, Zhiwei ^b   Hu, Hongxing ^a,d   Cheng, Genhong ^c   Zhou, Paul ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Cross protection; hemagglutinin; highly pathogenic avian influenza virus; human monoclonal antibody; newly emerging H5 viruses; oseltamivir

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; OSELTAMIVIR; SIALIC ACID; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; NA PROTEIN, INFLUENZA A VIRUS; NEUTRALIZING ANTIBODY; SIALIDASE; VIRAL PROTEIN;

ANTIBODY BLOOD LEVEL; CONTROLLED STUDY; CROSS PROTECTION; GENE MUTATION; HEMAGGLUTINATION; HIGHLY PATHOGENIC AVIAN INFLUENZA; IC50; INFLUENZA A; INFLUENZA B; MOUSE; NONHUMAN; PHAGE DISPLAY; PROTEIN PURIFICATION; SENSITIVITY ANALYSIS; SURVIVAL RATE; VIRUS NEUTRALIZATION; VIRUS PLAQUE; ANIMAL; ANTAGONISTS AND INHIBITORS; AVIAN INFLUENZA; BAGG ALBINO MOUSE; CHICKEN; CHINA; FEMALE; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H5N8);

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODIES, NEUTRALIZING; ANTIVIRAL AGENTS; CHICKENS; CHINA; FEMALE; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS, H5N8 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NEURAMINIDASE; OSELTAMIVIR; VIRAL PROTEINS;

EID: 84973117979     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.1080/19420862.2016.1183083     Document Type: Article

References (40)

1. OIE. Update on highly pathogenic avian influenza in animals (type H5 and H7). Paris, France: World Organization for Animal Health, 2016
2. WHO. Influenza at the human-animal interface, monthly risk assessment summary. Geneva, Switzerland: World Health Organization, 2016
3. E.de Vries, H.Guo, M.Dai, P.J.Rottier, F.J.van Kuppeveld, C.A.de Haan. Rapid emergence of highly pathogenic avian influenza subtypes from a subtype H5N1 hemagglutinin variant. Emerg Infect Dis 2015; 21:842-6; PMID:25897518; doi 10.3201/eid2105.141927
4. J.S.Hall, R.J.Dusek, E.Spackman. Rapidly Expanding Range of Highly Pathogenic Avian Influenza Viruses. Emerg Infect Dis 2015; 21:1251-2; PMID:26079209; doi 10.3201/eid2107.150403
5. J.H.Verhagen, S.Herfst, R.A.Fouchier. Infectious disease. How a virus travels the world. Science 2015; 347:616-7; PMID:25657235; doi 10.1126/science.aaa6724
6. WHO. Archive of avian influenza disease outbreak news. Geneva, Switzerland: World Health Organization, 2016
7. Z.Y.Yang, C.J.Wei, W.P.Kong, L.Wu, L.Xu, D.F.Smith, G.J.Nabel. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 2007; 317:825-8; PMID:17690300; doi 10.1126/science.1135165
8. M.W.Chen, T.J.Cheng, Y.Huang, J.T.Jan, S.H.Ma, A.L.Yu, C.H.Wong, D.D.Ho. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A 2008; 105:13538-43; PMID:18765801; doi 10.1073/pnas.0806901105
9. J.A.Schwartz, L.Buonocore, A.L.Suguitan, Jr., A.Silaghi, D.Kobasa, G.Kobinger, H.Feldmann, K.Subbarao, J.K.Rose. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. J Virol 2010; 84:4611-8; PMID:20181720; doi 10.1128/JVI.02637-09
10. J.E.Ledgerwood, C.J.Wei, Z.Hu, I.J.Gordon, M.E.Enama, C.S.Hendel, P.M.McTamney, M.B.Pearce, H.M.Yassine, J.C.Boyington, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis 2011; 11:916-24; PMID:21975270; doi 10.1016/S1473-3099(11)70240-7
11. M.F.Ducatez, J.Bahl, Y.Griffin, E.Stigger-Rosser, J.Franks, S.Barman, D.Vijaykrishna, A.Webb, Y.Guan, R.G.Webster, et al. Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development. Proc Natl Acad Sci U S A 2011; 108:349-54; PMID:21173241; doi 10.1073/pnas.1012457108
12. F.Zhou, G.Wang, P.Buchy, Z.Cai, H.Chen, Z.Chen, G.Cheng, X.F.Wan, V.Deubel, P.Zhou. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses. J Virol 2012; 86:6970-8; PMID:22496212; doi 10.1128/JVI.06930-11
13. G.Wang, F.Zhou, P.Buchy, T.Zuo, H.Hu, J.Liu, Y.Song, H.Ding, C.Tsai, Z.Chen, et al. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin. J Infect Dis 2014; 209:676-85; PMID:23911711; doi 10.1093/infdis/jit414
14. M.Throsby, E.van den Brink, M.Jongeneelen, L.L.Poon, P.Alard, L.Cornelissen, A.Bakker, F.Cox, E.van Deventer, Y.Guan, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 2008; 3:e3942; PMID:19079604; doi 10.1371/journal.pone.0003942
15. J.Sui, W.C.Hwang, S.Perez, G.Wei, D.Aird, L.M.Chen, E.Santelli, B.Stec, G.Cadwell, M.Ali, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009; 16:265-73; PMID:19234466; doi 10.1038/nsmb.1566
16. C.P.Simmons, N.L.Bernasconi, A.L.Suguitan, K.Mills, J.M.Ward, N.V.Chau, T.T.Hien, F.Sallusto, Q.Ha do, J.Farrar, et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 2007; 4:e178; PMID:17535101; doi 10.1371/journal.pmed.0040178
17. L.Sun, X.Lu, C.Li, M.Wang, Q.Liu, Z.Li, X.Hu, J.Li, F.Liu, Q.Li, et al. Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One 2009; 4:e5476; PMID:19421326; doi 10.1371/journal.pone.0005476
18. H.Hu, J.Voss, G.Zhang, P.Buchy, T.Zuo, L.Wang, F.Wang, F.Zhou, G.Wang, C.Tsai, et al. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. J Virol 2012; 86:2978-89; PMID:22238297; doi 10.1128/JVI.06665-11
19. D.Corti, J.Voss, S.J.Gamblin, G.Codoni, A.Macagno, D.Jarrossay, S.G.Vachieri, D.Pinna, A.Minola, F.Vanzetta, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011; 333:850-6; PMID:21798894; doi 10.1126/science.1205669
20. C.Dreyfus, N.S.Laursen, T.Kwaks, D.Zuijdgeest, R.Khayat, D.C.Ekiert, J.H.Lee, Z.Metlagel, M.V.Bujny, M.Jongeneelen, et al. Highly conserved protective epitopes on influenza B viruses. Science 2012; 337:1343-8; PMID:22878502; doi 10.1126/science.1222908
21. X.Zhu, Y.H.Guo, T.Jiang, Y.D.Wang, K.H.Chan, X.F.Li, W.Yu, R.McBride, J.C.Paulson, K.Y.Yuen, et al. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin. J Virol 2013; 87:12619-35; PMID:24049169; doi 10.1128/JVI.01577-13
22. L.Du, L.Jin, G.Zhao, S.Sun, J.Li, H.Yu, Y.Li, B.J.Zheng, R.C.Liddington, Y.Zhou, et al. Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin. J Virol 2013; 87:2215-25; PMID:23221567; doi 10.1128/JVI.02344-12
23. R.D.de Vries, H.L.De Gruyter, T.M.Bestebroer, M.Pronk, R.A.Fouchier, A.D.Osterhaus, G.Sutter, J.H.Kreijtz, G.F.Rimmelzwaan. Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine. Emerg Infect Dis 2015; 21:1086-8; PMID:25988813; doi 10.3201/eid2106.150021
24. R.Yoshida, M.Igarashi, H.Ozaki, N.Kishida, D.Tomabechi, H.Kida, K.Ito, A.Takada. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog 2009; 5:e1000350; PMID:19300497; doi 10.1371/journal.ppat.1000350
25. X.Wu, Z.Y.Yang, Y.Li, C.M.Hogerkorp, W.R.Schief, M.S.Seaman, T.Zhou, S.D.Schmidt, L.Wu, L.Xu, et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010; 329:856-61; PMID:20616233; doi 10.1126/science.1187659
26. M.Qian, H.Hu, T.Zuo, G.Wang, L.Zhang, P.Zhou. Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin. J Virol 2013; 87:3571-7; PMID:23269809; doi 10.1128/JVI.01292-12
27. T.Zuo, J.Sun, G.Wang, L.Jiang, Y.Zuo, D.Li, X.Shi, X.Liu, S.Fan, H.Ren, et al. Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nat Commun 2015; 6:8855; PMID:26635249; doi 10.1038/ncomms9855
28. S.Khurana, A.L.Suguitan, Jr., Y.Rivera, C.P.Simmons, A.Lanzavecchia, F.Sallusto, J.Manischewitz, L.R.King, K.Subbarao, H.Golding. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 2009; 6:e1000049; PMID:19381279; doi 10.1371/journal.pmed.1000049
29. A.Moscona. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353:1363-73; PMID:16192481; doi 10.1056/NEJMra050740
30. D.H.Lee, M.K.Torchetti, K.Winker, H.S.Ip, C.S.Song, D.E.Swayne. Intercontinental Spread of Asian-Origin H5N8 to North America through Beringia by Migratory Birds. J Virol 2015; 89:6521-4; PMID:25855748; doi 10.1128/JVI.00728-15
31. A.Moscona. Medical management of influenza infection. Annu Rev Med 2008; 59:397-413; PMID:17939760; doi 10.1146/annurev.med.59.061506.213121
32. T.C.Luke, E.M.Kilbane, J.L.Jackson, S.L.Hoffman. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 2006; 145:599-609; PMID:16940336; doi 10.7326/0003-4819-145-8-200610170-00139
33. J.M.Puck, W.P.Glezen, A.L.Frank, H.R.Six. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980; 142:844-9; PMID:7462695; doi 10.1093/infdis/142.6.844
34. C.Sweet, R.A.Bird, K.Jakeman, D.M.Coates, H.Smith. Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines. Immunology 1987; 60:83-9; PMID:3817868
35. C.Sweet, K.J.Jakeman, H.Smith. Role of milk-derived IgG in passive maternal protection of neonatal ferrets against influenza. J Gen Virol 1987; 68 (Pt 10):2681-6; PMID:3668509; doi 10.1099/0022-1317-68-10-2681
36. B.Zhou, N.Zhong, Y.Guan. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007; 357:1450-1; PMID:17914053; doi 10.1056/NEJMc070359
37. E.Hoffmann, G.Neumann, Y.Kawaoka, G.Hobom, R.G.Webster. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 2000; 97:6108-13; PMID:10801978; doi 10.1073/pnas.100133697
38. H.Ding, C.Tsai, R.A.Gutierrez, F.Zhou, P.Buchy, V.Deubel, P.Zhou. Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus. PLoS One 2011; 6:e16563; PMID:21305045; doi 10.1371/journal.pone.0016563
39. C.Tsai, C.Caillet, H.Hu, F.Zhou, H.Ding, G.Zhang, B.Zhou, S.Wang, S.Lu, P.Buchy, et al. Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine 2009; 27:6777-90; PMID:19732860; doi 10.1016/j.vaccine.2009.08.056
40. Network WGIS. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva, Switzerland: World Health Organization, 2011